Iquleare Chewable Tablets 5 mg (Montelukast Sodium)

Adult dose

This medication should be taken once daily, preferably in the evening for asthma patients. For patients with both asthma and allergic rhinitis, take one tablet once daily in the evening. This medication should be taken one hour before meals or two hours after meals.

Child dose

Children aged 6 to 14 years should chew 5 mg of Montelukast once daily. This medication should be taken one hour before meals or two hours after meals.

This medication is used to treat asthma and allergic rhinitis. This medication contains the artificial sweetener aspartame, which is broken down into phenylalanine in the body. Therefore, patients with the genetic disorder phenylketonuria should not take this medication. Patients who have an allergic reaction to this medication or its components should also avoid taking it. While taking this medication, side effects such as fatigue, headaches, abdominal pain, fever, cough, nasal congestion, and rash may occur, and if symptoms persist or worsen, consultation with a doctor is necessary. Particularly in children and adolescents, various adverse reactions such as pharyngitis, nausea, diarrhea, and ear infections have been reported, so caution is required. This medication is not intended for the treatment of acute asthma attacks, and patients should always have appropriate emergency medications on hand when acute symptoms occur. Inhaled corticosteroids should not be abruptly discontinued or substituted, and dosage should be adjusted gradually according to a doctor's instructions. Neurological and psychiatric symptoms such as anxiety, depression, hallucinations, and suicidal thoughts may occur during treatment, so such symptoms should be reported to a doctor immediately. To prevent bronchospasm due to exercise, do not use this medication alone; it should be used in combination with inhaled beta-2 agonists. Patients with hypersensitivity to aspirin or non-steroidal anti-inflammatory drugs should avoid taking such medications while on this treatment. Rarely, serious symptoms such as eosinophilia and vasculitis may occur during treatment, so monitoring by a doctor is necessary. No specific interaction reports have been noted when used with other medications; however, caution is required when taking with drugs that induce liver metabolism. During pregnancy or breastfeeding, this medication should only be taken when absolutely necessary, and consultation with a doctor is required. It can also be safely used in children and elderly patients, but safety and efficacy have not been established in children under 6 months of age. In case of overdose, there is no specific antidote, and appropriate treatment should be administered based on symptoms. When storing, keep this medication out of reach of children and preferably in its original container. This medication should be taken consistently even during periods without asthma symptoms, and consultation with a doctor is essential if symptoms worsen.

Serious side effects

Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, toxic epidermal necrolysis, Stevens-Johnson syndrome, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of mouth/eyes, respiratory distress, asthma attacks, respiratory abnormality accompanied by cough and fever, yellowing of skin or eyes (jaundice), extreme drowsiness, sudden and very severe headaches, thunderclap headache, seizures, loss of consciousness

Mild side effects

• Weakness
• fatigue
• fever
• abdominal pain
• trauma
• dyspepsia
• infectious gastroenteritis
• dental pain
• dizziness
• headaches

This medication is sensitive to moisture and light, so it is important to store it in a dry place away from light. The appropriate storage temperature is between 1°C and 30°C at room temperature, and it should be kept in a sealed container to maintain its effectiveness.

Appearance

Pink round chewable tablet with a convex shape on both sides

Package unit

30 tablets/PTP[(10 tablets/PTP)x3], 28 tablets/PTP[(7 tablets/PTP)x4]